Cargando…
Methylglyoxal induces p53 activation and inhibits mTORC1 in human umbilical vein endothelial cells
Methylglyoxal (MGO), a precursor of advanced glycation end products (AGEs), is regarded as a pivotal mediator of vascular damage in patients with diabetes. We have previously reported that MGO induces transcriptional changes compatible with p53 activation in cultured human endothelial cells. To furt...
Autores principales: | Zhang, Xinmiao, Rodriguez-Niño, Angelica, Pastene, Diego O., Pallavi, Prama, van den Born, Jacob, Bakker, Stephan J. L., Krämer, Bernhard K., Yard, Benito A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044125/ https://www.ncbi.nlm.nih.gov/pubmed/33850227 http://dx.doi.org/10.1038/s41598-021-87561-9 |
Ejemplares similares
-
Methylglyoxal down-regulates the expression of cell cycle associated genes and activates the p53 pathway in human umbilical vein endothelial cells
por: Braun, Jana D., et al.
Publicado: (2019) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Biphasic Effects of Blue Light Irradiation on Human Umbilical Vein Endothelial Cells
por: Kan, Kejia, et al.
Publicado: (2021) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Serum Carnosinase-1 and Albuminuria Rather than the CNDP1 Genotype Correlate with Urinary Carnosinase-1 in Diabetic and Nondiabetic Patients with Chronic Kidney Disease
por: Rodriguez-Niño, Angelica, et al.
Publicado: (2019)